Study on safety and efficacy of concentrated potassium chloride infusions in critically ill patients with hypokalemia

OBJECTIVE: To explore the safety and clinical efficacy of intravenous infusion of concentrated potassium chloride using micro-pumps in critically ill patients with hypokalemia

Bibliographische Detailangaben
Veröffentlicht in:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue. - 1998. - 20(2008), 7 vom: 16. Juli, Seite 416-8
1. Verfasser: He, Qing (VerfasserIn)
Weitere Verfasser: Wang, Jing-hua, Liu, Ya-lin, Tang, Pu-xian, Chang, Zhi-gang, Du, Li-qing, Huang, Xiu-feng
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2008
Zugriff auf das übergeordnete Werk:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
Schlagworte:English Abstract Journal Article Randomized Controlled Trial Potassium Chloride 660YQ98I10
LEADER 01000caa a22002652 4500
001 NLM180754351
003 DE-627
005 20250209144502.0
007 tu
008 231223s2008 xx ||||| 00| ||chi c
028 5 2 |a pubmed25n0603.xml 
035 |a (DE-627)NLM180754351 
035 |a (NLM)18611341 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a He, Qing  |e verfasserin  |4 aut 
245 1 0 |a Study on safety and efficacy of concentrated potassium chloride infusions in critically ill patients with hypokalemia 
264 1 |c 2008 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 04.02.2010 
500 |a Date Revised 21.11.2013 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: To explore the safety and clinical efficacy of intravenous infusion of concentrated potassium chloride using micro-pumps in critically ill patients with hypokalemia 
520 |a METHODS: One hundred and twenty-eight critically ill patients with hypokalemia, the endogenous creatinine clearance rate over 0.5 ml/second and the urine output over 50 ml/hour were randomly divided into the therapy group (n=64) and the control group (n=64). Patients in therapy group received 1,208 mmol/L (9%) KCl, while those in the control group received 201 mmol/L (1.5%) potassium chloride, intravenously with the aid of a micro-pump, with hourly equal quantity of KCl in both groups. Patients in both groups were monitored strictly, and the potassium infusion was stopped whenever the serum potassium exceeded or equal to 3.5 mmol/L 
520 |a RESULTS: It took (15.55+/-3.22) hours and (14.18+/-4.93) hours for the therapy group and the control group to correct the hypokalemia respectively, and there was no significant difference (P>0.05). Potassium infusion brought larger amount of fluid in the control group than the therapy group [(124.36+/-25.79) ml vs. (680.83+/-236.70) ml, P<0.01]. All patients tolerated the infusion without evidence of hemodynamic change, hyperkalemia or acute heart dysfunction. For all the patients, renal function did not throw significant influence on the potassium infusion time. An inverse correlation was observed between preinfusion potassium concentration and the quantity of potassium infused (r= -0.259, P<0.01) 
520 |a CONCLUSION: Under meticulous monitoring, it is safe and effective to infuse concentrated potassium for the critically ill patients with hypokalemia. This strategy can also be followed in patients with mild renal dysfunction but without oliguria or anuria under careful monitoring 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 4 |a Randomized Controlled Trial 
650 7 |a Potassium Chloride  |2 NLM 
650 7 |a 660YQ98I10  |2 NLM 
700 1 |a Wang, Jing-hua  |e verfasserin  |4 aut 
700 1 |a Liu, Ya-lin  |e verfasserin  |4 aut 
700 1 |a Tang, Pu-xian  |e verfasserin  |4 aut 
700 1 |a Chang, Zhi-gang  |e verfasserin  |4 aut 
700 1 |a Du, Li-qing  |e verfasserin  |4 aut 
700 1 |a Huang, Xiu-feng  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue  |d 1998  |g 20(2008), 7 vom: 16. Juli, Seite 416-8  |w (DE-627)NLM098227793  |x 1003-0603  |7 nnns 
773 1 8 |g volume:20  |g year:2008  |g number:7  |g day:16  |g month:07  |g pages:416-8 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 20  |j 2008  |e 7  |b 16  |c 07  |h 416-8